Refractory Lymphocytic Enterocolitis and Tumor Necrosis Factor Antagonist Therapy

Clinical Gastroenterology and Hepatology

Volumn 8, Issue 4, 2010, Pages 391-394

  Aram, Ghazaleh ^a   Bayless, Theodore M ^a   Chen, Zong Ming ^a   Montgomery, Elizabeth A ^a   Donowitz, Mark ^a   Giardiello, Francis M ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Diarrhea; Lymphocytic Enterocolitis; Refractory Sprue; Tumor Necrosis Factor Antagonist

Indexed keywords

ADALIMUMAB; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; AZATHIOPRINE; BUDESONIDE; CIPROFLOXACIN; CLONIDINE; COLESTYRAMINE; CORTICOSTEROID; ETANERCEPT; INFLIXIMAB; INSULIN GLARGINE; LEVOTHYROXINE SODIUM; METHYLPREDNISOLONE SODIUM SUCCINATE; METRONIDAZOLE; OMEGA 3 FATTY ACID; OMEPRAZOLE; OPIATE; RIFAMIXIN; STEROID; TRAZODONE; TUMOR NECROSIS FACTOR INHIBITOR; UNCLASSIFIED DRUG;

ADULT; AGED; ALLERGIC REACTION; ARTICLE; CASE REPORT; CLINICAL TRIAL; DIABETES MELLITUS; DIARRHEA; DISEASE SEVERITY; DRUG WITHDRAWAL; ENTEROCOLITIS; EVENING DOSAGE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPOTHYROIDISM; INFECTIOUS DIARRHEA; LYMPHOCYTIC ENTEROCOLITIS; MALABSORPTION; RHEUMATOID ARTHRITIS; SYMPTOM; TREATMENT FAILURE;

AGED; ANTIBODIES, MONOCLONAL; COLITIS, LYMPHOCYTIC; COLON; FEMALE; HISTOCYTOCHEMISTRY; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOLOGIC FACTORS; INTESTINE, SMALL; MICROSCOPY; MIDDLE AGED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77949649052     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2009.12.010     Document Type: Article

References (12)

1. Schiller L.R. Diagnosis and management of microscopic colitis syndrome. J Clin Gastroenterol 38 (2004) S27-S30
2. Dubois R., Lazenby A., Yardley J., et al. Lymphocytic enterocolitis in patients with refractory sprue. JAMA 262 (1989) 935-937
3. Mosnier J.F., Larvol L., Barge J., et al. Lymphocytic and collagenous colitis: an immunohistochemical study. Am J Gastroenterol 91 (1996) 709-713
4. Verkarre V., Asnafi V., Lecomte T., et al. Refractory celiac sprue is a diffuse gastrointestinal disease. Gut 52 (2003) 205-211
5. Brar P., Lee S., Lewis S., et al. Budesonide in the treatment of refractory celiac disease. Am J Gastroenterol 102 (2007) 2265-2269
6. Rai R.M., Hendrix T.R., Moskaluk C., et al. Treatment of idiopathic lymphocytic enterocolitis with oral beclomethasone dipropionate. Am J Gastroenterol 92 (1997) 147-149
7. Deslandres C., Moussavou-Kombilia J.B., Russo P., et al. Steroid-resistant lymphocytic enterocolitis and bronchitis responsive to 6-mercaptopurine in an adolescent. J Pediatr Gastroenterol Nutr 25 (1997) 341-346
8. Gillett H.R., Arnott I.D., McIntyre M., et al. Successful infliximab treatment for steroid-refractory celiac disease: a case report. Gastroenterology 122 (2002) 800-805
9. Turner S.M., Moorghen M., and Probert C.S.J. Refractory celiac disease: remission with infliximab and immunomodulators. Eur J Gastroenterol Hepatol 17 (2005) 667-669
10. Valesini G., Iannuccelli C., Marocchi E., et al. Biological and clinical effects of anti TNFalpha treatment. Autoimmun Rev 7 (2007) 35-41
11. Sandborn W.J., Hanauer S.M., Katx S., et al. Etanercept for active Crohn's disease: a randomized, double-blind, placebo-controlled trial. Gastroenterology 121 (2001) 1088-1094
12. van den Brande J.H.M., Braat H., van den Brink G.R., et al. Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn's disease. Gastroenterology 124 (2003) 1774-1785